People · Operator
Named in public records as an officer, director or promoter · active 2009–2012 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cardioxyl Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $52.0M | $953.8M | 2009 |
| ENTREC Corp | — | Other | Series A | $6.2M | $23.3M | 2012 |
Charles Sanders at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Sanders on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Garland | 1 | 7 |
| John Stevens | 1 | 6 |
| Peter A. Thompson | 1 | 5 |
| Jeff Clark | 1 | 5 |
| Christopher A. Kroeger | 1 | 4 |
| John Barrett | 1 | 4 |
| Charles A. Sanders | 1 | 3 |
| John A. Reardon | 1 | 2 |
| Joe Brennan | 1 | 2 |
| John Hudson | 1 | 2 |
| James A. Barrett | 1 | 2 |
| Peter Lacey | 1 | 2 |
| Anthony A. Johnson | 1 | 1 |
| Jeff A. Clark | 1 | 1 |
| Vince A. Kalish | 1 | 1 |
| Reza A. Mazhari | 1 | 1 |
| Reza Mazhari | 1 | 1 |
| Chris Porter | 1 | 1 |
| Rod Marlin | 1 | 1 |
| Brian Tod | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.